Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04447729
Recruitment Status : Withdrawn (Withdrawn due to logistic reasons)
First Posted : June 25, 2020
Last Update Posted : November 9, 2021
Information provided by (Responsible Party):
Teva Branded Pharmaceutical Products R&D, Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : February 10, 2022
Estimated Study Completion Date : February 10, 2022